Tuesday, March 02, 2021 9:40:05 PM
I just don't understand the FDA & relief therapeutics. Dr. J was the consult with knowledge of clinical trials. Why didn't he consult on trial size to relief therapeutics? FDA is looking at size and mortality instead of results. I don't think the FDA can reverse the phases of trials. If there is no eau in March or April, I'll be cashing out. FDA should approve zyesami. In light of recent results of zyesami decreasing time hospitalization by 10 days. Relief therapeutics had better get a great PR out & soon. Or else have a massive exodus of investors. There are other uses for zyesami. But FDA will have relief therapeutics go through 15 years of clinical trials before approval....insane!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM